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Plants contain numerous glycoconjugates that are metabolized by specific
glucosyltransferases and hydrolyzed by specific glycosidases, some also catalyzing
synthetic transglycosylation reactions. The documented value of plant-derived
glycoconjugates to beneficially modulate metabolism is first addressed. Next, focus
is given to glycosidases, the central theme of the review. The therapeutic value of
plant glycosidases is discussed as well as the present production in plant platforms of
therapeutic human glycosidases used in enzyme replacement therapies. The increasing
knowledge on glycosidases, including structure and catalytic mechanism, is described.
The novel insights have allowed the design of functionalized highly specific suicide
inhibitors of glycosidases. These so-called activity-based probes allow unprecedented
visualization of glycosidases cross-species. Here, special attention is paid on the use
of such probes in plant science that promote the discovery of novel enzymes and the
identification of potential therapeutic inhibitors and chaperones.
Keywords: plant glycosides, carbohydrate processing enzymes, glycosidases, glycosylation, enzyme
replacement therapy (ERT), plant production platforms, glycosphingolipids, glycosidase activity-based probes
INTRODUCTION
Plant Metabolites and Their Glycosylation
Plants provide nutrition and the human body has evolved to thrive optimally on this nourishment.
Besides the nutritional value, plant-derived food influences the microbiome in the gastrointestinal
tract with physiological effects (Theilmann et al., 2017). Plants produce a huge variety of secondary
metabolites that can be decorated with sugars, i.e., glycosylated (Jones and Vogt, 2001; Gachon
et al., 2005; Wink, 2015). Specific plant glycosyltransferases (GTs) using nucleotide-sugars as donors
can attach specific sugar moieties to an acceptor molecule (Henrissat and Davies, 2000; Jones and
Vogt, 2001). Glycosyl hydrolases, so-called glycosidases, remove specific sugar moieties. Most of
these enzymes are retaining exo-glycosidases (Coutinho et al., 2003). Some of these glycosidases
are also able to synthetically transglycosylate in the presence of high concentrations of an acceptor
molecule, a reaction implying the transfer of a sugar moiety from a substrate to an acceptor
molecule (Morant et al., 2008).
Glycosylation of metabolites in plants serves multiple purposes. Upon glycosylation,
hydrophobic metabolites become more water-soluble which improves their bio-distribution
and metabolism (Kren and Martinkova, 2001; Pandey et al., 2014). Increased solubility and
amphiphilicity of glycosylated metabolites may assist their transport across cell membranes
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(Vetter, 2000). The attachment of sugars to small metabolites
raises their molecular weight and melting point. This allows
synthesis and storage of precursors of volatile compounds
that can be released on demand after hydrolysis (Ohgami
et al., 2015). The stability of glycosylated metabolites may
depend on the position where the sugar moiety is attached,
for example the 6-O-glucosides of ascorbic acid are chemically
less stable than the 2-O-glucoside form or non-glycosylated
ascorbic acid (Jones and Vogt, 2001). Furthermore, detoxification
of harmful molecules can take place through glycosylation.
Glycosylation may generate a non-toxic agent that later can be
re-activated and used as aglycone in defense against parasites
and plant-eating organisms such as herbivores. Examples are
cyanogenic glycosides produced by plants. These consist of an
α-hydroxynitrile group attached to a sugar moiety, often a D-
glucose (Vetter, 2000). Release of cyanohydrin aglycone leads
to spontaneous transformation to the corresponding ketone
or aldehyde and release of hydrogen cyanide (prussic acid)
(Cressey and Reeve, 2019). Hydrolysis of cyanogenic glycosides
can be mediated by endogenous β-glucosidases when brought
into contact with the substrate upon damaging of plant cells
(Cressey and Reeve, 2019). Additionally, hydrolysis may take
place by the gut microbiome during digestion of plant material.
The first identified cyanogenic glycoside was amygdalin isolated
from almonds in 1830 (Robiquet and Boutron-Charlard, 1830).
Cyanogenic glycosides are ubiquitous in plants, being identified
in more than 2,500 species (Vetter, 2000). The sugars attached
to the aglycone may vary from a disaccharide to monosaccharide,
usually glucose (Vetter, 2000; Haque and Bradbury, 2002; Cressey
and Reeve, 2019). Cassava, M. esculenta, produces the cyanogenic
glycosides linamarin and lotaustralin and consumption may
cause severe pathology (Kamalu, 1991; Kamalu, 1993). Finally,
another example of regulating biological activity by glycosylation
is provided by glycosylated phytohormones such as abscisic
acid (ABA), auxin (IAA), cytokinins (CKs), brassinosteroids
(BRs), salicylic acid, and gibberellin that regulate growth,
development, and responses to environmental stresses (Gachon
et al., 2005). Glycosylation of phytohormones usually leads to
inactive storage forms of plant hormones that can be hydrolyzed
for activation, allowing rapid responses and maintaining the
hormonal homeostasis (Kren and Martinkova, 2001; Stupp et al.,
2013; Pandey et al., 2014).
In this review, we pay attention to the natural occurrence
of glycosides in plants with emphasis to glycolipids and touch
upon their metabolizing enzymes. We address the use of plant
lipids for therapeutic purposes as well as their potential harmful
effects. Described is the increasing use of plants as production
platforms for therapeutic enzymes, in particular glycosidases for
the treatment of lysosomal storage disorders. Finally, we discuss
the recent design of unprecedented tools to study glycosidases,
cross-species. These so-called activity-based probes (ABPs) are
modified cyclophellitols that allow in situ visualization of their
target glycosidases. ABPs label glycosidases cross-species due to
the highly conserved catalytic pockets and find many applications
like discovery of glycosidases in several organisms, diagnosis
of inherited lysosomal glycosidase deficiencies, visualization of
tissue distribution and subcellular localization of endogenous and
exogenous (therapeutic) glycosidases and the identification of
therapeutic inhibitors and chaperones.
BENEFICIAL GLYCOSYLATED PLANT
METABOLITES
Plant-Derived Agents and Human Health
Balanced consumption of vegetables is nowadays in the
center of attention, particularly prompted by the worldwide
epidemic of obesity and associated health problems. There is
considerable interest in plant products from practitioners of
regular medicine and pharmaceutical industry. Of note, the first
generation of pharmaceuticals largely consisted of plant-derived
products or minor chemical modifications thereof (Friend, 1974).
The longstanding popularity of natural plant products with
alternative medicine advocates stems in many cases from ancient
use of such materials in traditional medicine.
The chemical structure of plant glycosides determines their
biological action(s) and bioavailability (uptake). In this respect,
attention is first paid to glycosylated flavonoids.
Glycosylated Flavonoids
The predominant polyphenols in food (i.e., fruits, vegetables,
nuts) and beverages (i.e., tea, wine) are flavonoids (Pandey
and Rizvi, 2009; Pan et al., 2010). Plant flavonoids can be
categorized into subclasses: flavonols, isoflavonols, flavones,
flavanones, flavanols (catechins), and anthocyanidins (Ross and
Kasum, 2002; Xiao et al., 2014). Daily consumption of several
milligrams of flavonoids (25 mg to 1 g/day) is common (Hertog
et al., 1993; Tsuda et al., 1999; Ross and Kasum, 2002).
Many plant flavonoids (see Figure 1 for general structures) are
glycosylated (Day et al., 1998; Tohge et al., 2017). Glycosides are
linked to the phenolic hydroxyls, via α- or β-D-glycosidic linkages
(Murota and Terao, 2003). This type of modification may involve
a single oligosaccharide or in some cases a polysaccharide moiety
(Xiao et al., 2014). Commonly reported benefits of flavonoid
glycosides are anti-oxidants and anti-inflammatory activities
which find application in prevention and disease management
(Lin and Harnly, 2007; Xiao et al., 2014). To illustrate this, some
examples of each subclass are here discussed.
Flavonols are characterized by a phenolic substitution at
position 2 of its 3-hydroxyflavone backbone. Quercetin is a
flavonol present in plants, fruits and vegetables. It can occur
as diverse glucosylated forms: for example quercetin-4′-O-β-
D-glucoside or quercetin-3,4′-O-β-D-glucoside are predominant
in onion with the glucose attached at the 3 or/and 4′
position of the phenol respectively (Murota and Terao,
2003) (Figure 1A). It has been suggested that phenolic
hydroxyl groups contribute to the free radical scavenging
activity of the molecules (Bors et al., 1990). The health
benefits of quercetin are generally attributable to its anti-
oxidant action positively impacting on glutathione and reactive
oxygen species (ROS) (Xu et al., 2019). The anti-oxidant
action is in part mediated by the modulation of enzymes
associated with oxidative stress like acetylcholinesterase and
butyrylcholinesterase (Xu et al., 2019). Kaempferol, present in
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FIGURE 1 | Glycosylated plant metabolites beneficial for humans. Flavonoids and some of their glycoside metabolites: flavonols (A), flavones (B), isoflavones (C),
flavanones (D), flavanols (E), and anthocyanidins (F). Chemical structures of cardiac glycosides (G). Bufalin is an animal-derived cardiac glycoside.
broccoli, apples, tea, strawberries, and beans, is another flavonol
with reported antioxidant and anti-inflammatory properties
(Chen and Chen, 2013).
Whereas flavonols have an OH group at C-3, the flavones
bear a hydrogen in that position (Figure 1B). Apigenin and
luteolin are flavones found in plant food. Apigenin occurs
in a wide variety of vegetables and fruits such as parsley,
celery, chamomile, oranges, thyme, onions, honey, and spices,
as well as beverages derived from plants such as tea, beer,
and wine. It exists largely as C-glycosylated form, being
more stable and reactive than the O-glycosylated counterparts.
Apigenin is found to be absorbed as glycosylated structure
and to exert antioxidant, anti-inflammatory and anti-cancer
effects. For instance, glycosylated forms of apigenin with
various pharmacological activities are apigenin 6-C-glucoside
(isovitexin), apigenin 8-C-glucoside (vitexin), apigenin 7-O-
glucoside, and apigenin 7-O-neohesperidoside (rhoifolin) (He
et al., 2016). Luteolin, present in carrots, peppers, celery, olive
oil, peppermint, thyme, rosemary and oregano, is reported to
have antioxidant effects and it is assumed to inhibit angiogenesis,
induce apoptosis and thereby prevent carcinogenesis in vivo
(Lin et al., 2008). Well known glycosylated forms of luteolin in
citrus fruits are luteolin 7-O-rutinoside and lucenin-2 (luteolin
6,8-di-C-glucoside). Furthermore, cynaroside, the 7-O-glucoside
derivative of luteolin, is found in Lonicera japonica Thunb.
and Angelica keiskei. and also shows anti-oxidant and anti-
inflammatory activity (Lin et al., 2008; Lopez-Lazaro, 2009; Chen
et al., 2012; Nho et al., 2018).
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Isoflavones bear a phenolic moiety at position 3 instead of
2 (Figure 1C). Genistein, an isoflavone found predominantly
in soy, and together with its glycosylated form genistein, is
reported to provide multiple health benefits. Several studies
demonstrated that genistein has anti-diabetic effects, in particular
through direct positive effects on β-cells and glucose-stimulated
insulin secretion. In addition, protection against apoptosis is
reported, independent of its function as an estrogen receptor
agonist, antioxidant action, and inhibition of tyrosine kinase
activity (Fotsis et al., 1993; Record et al., 1995; Allred et al., 2001;
Pandey et al., 2014).
Flavanones are characterized by a saturated C2–C3 bond in
the C ring and normally occur as a racemic mixture (Figure 1D).
Hesperidin, a 7-O-rutinoside flavone, is a natural product with a
wide range of biological effects, in particular it presents inhibitory
effect against the development of neurodegenerative diseases
(Hajialyani et al., 2019). Hesperidin, a dietary flavanone, and
its aglycone hesperetin, are found predominantly in citrus fruits
such as oranges and lemons. These compounds are considered
to exert beneficial anti-inflammatory and anti-oxidative action
(De Souza et al., 2016).
Flavanols (a.k.a. catechins) have a 2-phenyl-3,4-dihydro-2H-
chromen-3-ol skeleton and are mainly found in tea. Contrary to
other flavonoids, flavanols are often not glycosylated and their
glycosylation normally decreases anti-oxidant activity (Plumb
et al., 1998). The beneficial effects of green tea have been
attributed to its high content of polyphenolic catechins, including
catechin (C), (−)-epicatechin (EC), (−)-epigallocatechin (EGC),
(−)-epicatechin-3-gallate (ECG), and (−)-epigallocatechin-3-
gallate (EGCG) (Figure 1E). Among them, EGCG is the
polyphenolic catechin with the highest antioxidant effect as ROS
scavenger and metal ion chelator, and it finds application in
prevention of disease caused by oxidative stress, such as cancer,
cardiovascular diseases, neurodegenerative disease, neuropathic
pain, and diabetes (Roghani and Baluchnejadmojarad, 2009;
Xifró et al., 2015).
Anthocyanidins possess a 2-phenylchromenylium ion
backbone and are the deglycosylated version of anthocyanins
(Figure 1F). Anthocyanins are abundant pigments in many
red berries with documented antioxidant action. Examples
are cyanidin-3-O-rutinoside and cyanidin-3,5-O-diglucoside
(Feng et al., 2016). Likewise, anti-inflammatory properties are
reported for the anthocyanidin malvidin-3-O-β-D-glucoside and
malvidin-3-O-β-D-galactoside in blueberries by blocking the
NF-κB pathway mechanism (Huang et al., 2014).
To which extent glycosylation of flavonoids contributes
to their beneficial action is not always well understood.
Glycosylation of flavonoids might favor bioavailability and
uptake into the body. One advantage of glycosylation is
that it can stabilize the molecules, preserving their structural
integrity and therefore enabling their accumulation. In addition,
glycosylation serves as a transport signal among the different
compartments of the plant cell. For example, cyanogenic
glucosides are transported only in their glycosylated form
(Jones and Vogt, 2001). Flavonoid glycosides may be converted
to their aglycones prior to absorption by intestinal epithelial
cells. However, some glycosylated flavonoids are apparently also
absorbed as such (for example, cyanidin-3-O-β-D-glucoside and
glycosylated apigenin) (Murota and Terao, 2003; Xiao et al.,
2014, 2016). The linked sugar moiety, the type of linkage (O-
versus C-) and the position of the glycoside attachment may
influence the bioactivity of a flavonoid. An example of the
latter forms the inferior free radical scavenging of quercetin-
4′-O-β-D-glucoside compared to quercetin-3-O-β-D-glucoside
(Yamamoto et al., 1999). This difference is due to the fact
that the flavonoids’ free radical scavenging activity depends
on phenolic hydroxyl groups which act as electron donors. In
particular, a catechol moiety with two neighboring hydroxyls
has high electron donation ability (Murota and Terao, 2003).
The antioxidant activities of glycosylated flavonoids can partly
be also attributed to their chelation action, with the catechol
group also playing an key role in the process (Murota and
Terao, 2003). Interestingly, C-glycosylation enhances some of
the beneficial traits of flavonoids such as their antioxidant and
anti-diabetic activities. O-Glycosylation is reported to reduce
flavonoid bioactivity and absorption (Hostetler et al., 2012;
Xiao et al., 2014).
The anti-inflammatory effects of flavonoids can be attributed
to reduction of cytokine-induced inflammation by the inhibition
of tumor necrosis factor-α (TNF-α) signaling and reduced
expression of pro-inflammatory genes by down-regulation of NF-
κB (Ramos, 2007; Pan et al., 2010; Huang et al., 2014). An example
is provided by the anti-inflammatory flavonol kaempferol which
is present in broccoli, tea and vegetables. During osteoporosis,
pro-inflammatory cytokines, e.g., TNF-α, are expressed and cause
bone disruption and further cytokine production. Kaempferol
antagonizes the TNF-α induced production of interleukin-6 (IL-
6) and monocyte chemotactic protein-1 (MCP1a), as well as
the RANKL triggered osteoclast precursor cell differentiation
(Pang et al., 2006; Pan et al., 2010). Another example is the
anti-inflammatory effect of glycosylated anthocyanins present
in blueberries, malvidin-3-O-glucoside and malvidin-3-O-β-
D-galactoside. These molecules reduce the levels of MCP1,
intercellular adhesion and vascular cell adhesion molecule-1
at protein and mRNA level in endothelial cells through the
inhibition of TNF-α. In addition, they block the NF-κB pathway
by affecting IκBα degradation and the nuclear translocation of
p65 (Huang et al., 2014).
For many flavonoids miscellaneous anti-cancer effects have
been reported. The presumed modes of action of flavonoids as
anti-cancer agents are diverse and the role of glycosylation in
such anti-tumor effect is often not well understood. Examples
of flavonoids with reported anti-tumor action are kaempferol
(Ramos, 2007; Chen and Chen, 2013), peonidin 3-O-β-D-
glucoside, genistein, genistin, and EGCG (Fotsis et al., 1993;
Record et al., 1995; Allred et al., 2001; Pandey et al., 2014;
Xifró et al., 2015). Genistein and genistin are, however, also
reported to stimulate breast cancer cells in vivo at very low
concentrations (nM range), acting as estrogen agonists in mice
mammary glands (Allred et al., 2001). Daidzin of soybeans is
another well-studied isoflavone 7-O-β-D-glucoside with similar
anti-cancer properties as genistein. Anti-cancer action has also
been documented during the last decades for apigenin, hesperidin
and its aglycone hesperetin (Madunić et al., 2018).
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Plant-derived cardiac glucosides are secondary metabolites
consisting of a steroid backbone functionalized with a lactone
ring at the 17-β position and a sugar moiety at the 3-β position
(Figure 1G). Cardiac glycosides can be classified as cardenolides
or bufadienolides depending on the 5- or 6-membered lactone
ring, respectively. Cardenolides are known since ancient times
for their positive effects on cardiac arrhythmia, congestive
heart failure and atrial fibrillation (Nesher et al., 2007). Their
main role as antiarrhythmic agents is based on their ability
to inhibit the Na+/K+ ATPase ion pump, thus increasing
intracellular potassium concentrations (Kelly, 1990; Kepp et al.,
2012; Patel, 2016). In response to this, intracellular calcium
increases which promotes more efficient myocardial contraction
and improves cardiac pump activity (Newman et al., 2008). Well
known examples of therapeutic cardiac glycosides are digoxin
and digitoxin from the foxglove plant Digitalis. Even though
the positive effects of cardiac glycosides are well established,
dose-dependent toxicity remains an issue (Ehle et al., 2011).
Bufadienolides are present in very low amounts in plants and are
prominent in animals such as the toad (Bufo), fireflies (Photinus),
and snake (Rhabdophis) (Steyn and Van Heerder, 1998).
GLYCOSYLATED LIPIDS
Diacylglycerols
Plants contain diverse glycosylated lipids. Galactosylated
diacylglycerols are ubiquitous glycolipids in plants. They are
predominantly found in photosynthetic tissues, such as the
leaf. In particular, chloroplast thylakoid membranes contain
high quantities of monogalactosyldiacylglycerol (MGDG)
and digalactosyldiacylglycerol (DGDG) (see Figure 2A for
the chemical structure and cellular localization) (Hölzl and
Dörmann, 2019). For instance, MGDG and DGDG account to
36% and 20%, respectively, of spinach chloroplast glycerolipids.
Less abundant are the acidic sulfoquinovosyldiacylglycerol (5%),
and other glycerophospholipids (Wintermans, 1960). Of note,
the existence of acylated MGDG (acylMGDG) has also been
documented by Nilsson et al. (2015) and their concentration
is increased during environmental stresses such as frost.
Glucosylated diacylglycerols are far rarer than galactosylated
counterparts in plants and animals. 1,2-Di-O-acyl-3-O-β-D-
glucopyranosyl-sn-glycerol has however been found in rice bran
(Holst, 2008).
Sphingolipids
Glycosylated sphingolipids (glycosphingolipids) in which
sugar(s) are attached to ceramide are very abundant in animal
cells. Distinct sphingolipids exist in plants (see Figure 2B for the
chemical structure and cellular localization). Plants produce, like
animals, the simple glycosphingolipid glucosylceramide (GlcCer)
where glucose is β-linked to a phytoceramide that differs from
animal ceramide in the composition of the sphingosine moiety
[also referred as long-chain base (LCB)] (Spassieva and Hille,
2003; Pata et al., 2010; Ali et al., 2018; Huby et al., 2019). Another
glycosylated sphingolipid in plants is glucosylinositol phosphoryl
ceramide (GIPC) (Ali et al., 2018). Whereas in animals the major
sphingosine base is C18 LCB, in plants over nine different LCBs
have been identified. In addition, the presence of dienes in the
plant sphingosine bases is rather common (Pruett et al., 2008;
Ali et al., 2018). Plant LCBs can occur in very low concentrations
in cells, but they are mainly present as backbones of ceramides
that further contain linked fatty acid chains (C16–C26). The
ceramides are next glycosylated forming GlcCer and/or GIPCs
(Ali et al., 2018). In plants, elongation of glucosylceramide
to oligoglycosylceramides occurs with either mannosyl or
galactosyl units (Lynch and Dunn, 2004). In the common
mannosyl series in higher plants, up to four mannosyl units
may be added via β1→4 linkages. Oligoglycosylceramides are
present in the endoplasmic reticulum (ER), Golgi apparatus,
vacuole membrane, and plasma membrane. Sphingolipids
and their glycosylated forms together with plant sterols are
important constituents of the lipid rafts of the plasma membrane
(Msanne et al., 2015). The complex GCIPC are considered as
the equivalents of complex glycosphingolipids like gangliosides
in animal cells (Gronnier et al., 2016; Cacas et al., 2016). They
play important roles in regulation of cellular processes, such as
cell wall formation, programmed cell death, drought and salt
tolerance (Ali et al., 2018).
Phytosterols (Plant Sterols and Stanols)
Phytosterols, also known as xenosterols, are essential components
of plant cells that are predominantly found in cell membranes
(Hartmann, 1998). They include plant sterols and stanols
(saturated sterols without double bonds in the sterol ring) (see
Figure 2C for chemical structure and cellular localization). Their
chemical structure consists of a sterol body; a cyclopentano-
perhydro-phenanthrene ring system (formed by four rigid rings)
with a hydroxyl group at position C-3 and a side chain attached
to the carbon C-17 (Figure 2C). Differences in the nature of the
side chain gives a plethora of diverse sterols in plants, accounting
to more than 260 different ones, as described over the last
decades (Vanmierlo et al., 2015). The most abundant phytosterols
in human diet are β-sitosterol, campesterol, campestanol, and
stigmasterol. Their structure is similar to the structure of the
mammalian sterol, cholesterol. Phytosterols structurally differ
from cholesterol only at the length and saturation of their
aliphatic side chain. For instance, campesterol has an additional
methyl group at its side chain, at C-24 position (Mamode Cassim
et al., 2019). It is important to mention that plants also contain
small amounts of cholesterol (Hartmann, 1998). Phytosterols
are mainly found in vegetable oils, seeds, and nuts and in less
extent in fruits and vegetables (Amiot et al., 2011). Phytosterols
play important roles in several biological processes. For instance,
campesterol is found to act as a precursor at the biosynthesis
of BRs, hormones that regulate plant growth, development and
morphogenesis. In addition, β-sitosterol and stigmasterol are
mainly involved in the maintenance of cell membranes, and
together with sphingolipids, form the lipid rafts (Amiot et al.,
2011; Ferrer et al., 2017). Phytosterols are also involved in
responses to biotic and abiotic stresses (Ferrer et al., 2017).
A characteristic example is the formation of stigmasterol in
Arabidopsis leaves after inoculation with specific bacteria. In
general, plant sterols play a key role in the innate immunity
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FIGURE 2 | Different classes of plant lipids and their localization in the plant cell. (A) Chemical structures of plant glycosylated lipids: monogalactosyldiacylglycerol
(MGDG) and digalactosyldiacylglycerol (DGDG). (B) Chemical structures of plant (glycosyl)sphingolipids: long-chain base (LCB) 4,8-sphingadienine, ceramide (Cer),
glucosylceramide (GlcCer), glucosylinositol phosphoryl ceramides (GIPC) and oligoglycosylceramide. (C) Chemical structures of plant sterols (green) versus the
animal counterparts (blue). Plant cell image illustrating the localization of lipid classes: (A) stands for MGDG and DGDG, (B) for plant (glycosyl)sphingolipids, and (C)
for plant sterols.
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of plants against bacterial infections via regulating the nutrient
efflux in the apoplast (Griebel and Zeier, 2010; Wang et al., 2012).
In addition, tolerance to aluminum is shown to be influenced
positively by the high sterol and low phospholipid contents in
the root tip of plants. This results in a less negatively charged
plasma membranes, tolerating better aluminum (Wagatsuma
et al., 2014). At last, drought tolerance is also associated with
sterol composition of the plants as studied via using the drought
hypersensitive/squalene epoxidase 1–5 mutants in Arabidopsis
(Posé et al., 2009).
Glucosylated Phytosterols and Medicinal
Properties
Conjugated forms of phytosterols occur. Examples are the
steryl glycosides (SG) (sometimes referred to as sterolins) and
their acylated forms; the acyl steryl glycosides (ASG). In plant
SG, the sugar moiety, often a glucose, is attached at the C-
3 hydroxyl group of the sterol. When the sugar moiety is
further acylated with a fatty acid at the primary alcohol (C-6
carbohydrate numbering), ASG is formed (Grille et al., 2010;
Nyström et al., 2012) (Figure 2C). The first glycosylated plant
sterol to be purified was ipuranol from the olive tree in 1908.
A few years later it was identified as β-sitosteryl-D-glycoside.
ASGs were next discovered in lipid extracts of soybean seeds
and potato tubers (Grille et al., 2010). Plant glycolipids occur
in different amounts and in different composition among plant
species even in different tissues from the same plant. High
levels of SG and ASG occur in Solanum species, accounting
to more than 50% of the total sterol levels (Nyström et al.,
2012; Ferrer et al., 2017). SG and ASG levels are high in fruit,
vegetable juices, beer, wine as well as in tomatoes and potatoes
(Decloedt et al., 2017).
Steryl glycosides and ASGs play important roles in biological
processes such as maintenance of the plasma membrane
organization and they allow adaptive responses to environmental
changes (Mamode Cassim et al., 2019). Several studies using
forward and reverse genetic approaches have revealed the
import role of SGs and ASGs in plants during different
environmental stresses. An example is provided by transgenic
Arabidopsis and tobacco plants, overexpressing a sterol GT from
W. somnifera, showing increased tolerance toward salt, heat and
cold. Furthermore, downregulation of the same gene product
results in increased susceptibility to plant pathogens (reviewed
in Ferrer et al., 2017). SGs and ASGs are also present in
pollen and phloem sap of Arabidopsis. It has been hypothesized
that SGs act as primers of cellulose synthesis (Ferrer et al.,
2017). The attached sugar to the sterol increases drastically the
hydrophilicity of phytosterols and might increase the ability to
interact with proteins embedded in membranes as well as with
other glycolipids in lipid rafts. The same has been proposed
for the amphiphilic cardiac glycosides ouabain and digitalin
(Tabata et al., 2008).
Phytosterols are nowadays widely used as food additives
aiming to lower plasma LDL cholesterol and reduce cholesterol
absorption in humans. Already in the early 1950s, intake of plant
sterols was reported to reduce the total plasma cholesterol and
LDL-cholesterol and cholesterol absorption efficiency (Peterson,
1951). After this, a vast number of studies and clinical trials
demonstrated cholesterol-lowering effects of a phytosterol-rich
diet. This led to the industrial production of phytosterol enriched
food products such as margarines and yogurts (AbuMweis and
Jones, 2008; Amiot et al., 2011; Trautwein et al., 2018; Nakano
et al., 2019). It is generally accepted that 1–3 g of a daily dose of
phytosterols leads to a 10–15% decrease of total cholesterol levels
and also decreases plasma LDL-cholesterol (Patel et al., 2018;
Nakano et al., 2019).
The metabolic response to phytosterols varies among
individuals (Jones, 2015). This can be due to genetic differences,
for example in genes encoding ApoE and CyP7A1. Of particular
interest in this connection are also ATP-binding cassette
(ABC) subfamily G member 5 (ABCG5) and member 8
(ABCG8), which are proteins involved in phytosterol transport.
Mutations in ABCG5 or ABCG8 cause sitosterolemia, a
devastating disease first described by Bhattacharyya and Connor
(1974), Tada et al. (2018), Plat et al. (2019). The ABCG5
and ABCG8 proteins act as heterodimers, forming together
with other proteins a functional sterol transport complex,
and are expressed in hepatocytes, gallbladder epithelium, and
enterocytes. ABCG5/ABCG8 excretes phytosterols and other
xenosterols from cells, even better than cholesterol. Impaired
ABCG5/ABCG8 leads to accumulation of phytosterols in the
body causing macrothrombocytopenia, platelet dysfunction, liver
disease, cholesterol accumulation with xanthoma formation and
atherosclerosis (Silbernagel et al., 2013; Patel et al., 2018).
Little is still known on the impact of SGs and ASGs on the
human body. The β-sitosterol-β-D-glycoside (BSSG) is relatively
abundant in the human diet (Decloedt et al., 2017). Both
β-sitosterol (BSS) and its glycosylated form are found in human
plasma and tissues in very low levels, at 800–1,000 less compared
to endogenous cholesterol (Pegel, 1997). It has been shown that
upon chronic high intake plant sterols accumulate in the brain
(Vanmierlo et al., 2012; Saeed et al., 2015). Even though the
mammalian blood brain barrier (BBB) is not, or very poorly,
permeable to cholesterol, studies have shown that phytosterols
like sitosterol and campesterol are able to cross the BBB in mice.
β-Sitosterol and BSSG are proposed to exert beneficial anti-
inflammatory actions and to reduce mild hypercholesterolemia
(Bouic et al., 1999). Bouic et al. (1999) observed that
administering a mixture of BSS/BSSGs to marathon runners
had a positive effect on the immune system under physical
stress conditions. On the other hand, BSSGs were also found
to be toxic to motor neurons in vitro (Tabata et al., 2008). The
exposure to high amounts of BSSGs amounts present in the seed
of the cycad tree (Cycas micronesica) has been speculated to
underly the historical high prevalence of the neurodegenerative
disease amyotrophic lateral sclerosis–parkinsonism dementia
complex (ALS–PDC) at the island of Guam (Tabata et al.,
2008). Indeed, feeding of BSSGs to rats is found to cause
several neurological signs and defects resembling those occurring
in Parkinson disease patients, such as α-synuclein aggregates,
motor abnormalities and striatal dopamine loss (Shen et al.,
2010; Van Kampen et al., 2014; Kampen et al., 2015; Franco
et al., 2018). Van Kampen et al. (2014) successfully induced
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Parkinsonism in Sprague Dawley rats by feeding them with
BSSG for 4 months.
ABSORPTION AND METABOLISM OF
PLANT GLYCOCONJUGATES
Knowledge on the absorption and metabolism of individual
plant glycoconjugates is warranted to better understand their
mechanism of action. It appears that upon ingestion the fate of
individual glycoconjugates may fundamentally differ.
Uptake of Glycosylated Flavonoids
For decades it was widely believed that prior to uptake in
the body glycosylated flavonoids, such as quercitrin, rutin,
and robinin, common components of human diets, were first
deglycosylated by intestinal glycosidases and bacterial enzymes
in the intestine (Griffiths and Barrow, 1972; Bokkenheuser
et al., 1987). Only the produced aglycones would be partially
absorbed in the large intestine (Walle, 2004). Following uptake,
flavonoids are glucuronidated, O-methylated or sulfated in the
liver. Part of them are subsequently excreted into the bile and
undergo enterohepatic cycling to finally being eliminated by
renal excretion (Murota and Terao, 2003). An example of such
metabolism is that of the flavanone hesperidin, mainly found in
citrus fruits such as oranges and lemons. Hesperidin (hesperetin
with a linked rutinoside moiety) is absorbed as the aglycone
hesperetin, after removal of the glycose moiety by intestinal
bacteria. However, rapid absorption of α-glucosylated hesperidin
(G-hesperidin) containing an additional linked α-glucosyl moiety
has been observed, possibly due to its high water solubility (De
Souza et al., 2016). It has become apparent that deglycosylation
of some flavonoids may not depend on intestinal bacteria.
Saliva has been also suggested to play a role in the hydrolysis
of the dietary flavonoids. Browning et al. (2005) performed a
study on different glycosylated flavonoids like quercitrin, rutin,
isoquercitrin, spiraeoside, genistin, naringin, and phloridzin
(Browning et al., 2005). Their findings suggest that saliva
enzymes may hydrolyze the glycosylated flavonoids, in particular,
glucosides. For instance, quercetin-4′-O-glucoside and genistein-
7-O-glucoside, found in high amounts in dietary products, are
rapidly hydrolyzed in the oral cavity. Saliva is also suggested to
already hydrolyze quercetin glucosides (Hirota et al., 2001).
Dietary glycosylated anthocyanins, such as cyanidin-3-O-
glucoside and cyanidin-3,5-O-diglucoside, are absorbed in intact
form (Miyazawa et al., 1999). Quercetin glycosides are known
to be taken up in the small intestine via the sodium dependent
glucose transporter SGLT1 (Hollman et al., 1995; Walgren et al.,
1998, 2000). Phloridzin, the glucoside of the flavonoid phloretin,
was also found to be transported by SGLT1 (Walle and Walle,
2003). Takahashi et al. (2019) recently observed that intestinal
absorption of galactosylated-cyanidin is inferior to that of the
glucosylated one. Of note, absorbed glycosylated anthocyanins
may pass the BBB and reach different brain regions like the
cortex and hippocampus (Milbury et al., 2002; Milbury and
Kalt, 2010; Zhang et al., 2019). Phloridzin and other flavonoid
glycosides (quercetin and genistein) have also been identified
as substrates for efflux by the multidrug resistance-associated
protein transporters MRP1 and MRP2 (Walle and Walle, 2003).
Thus, dietary glycosylated anthocyanins seem to manage to reach
visceral tissues and the brain by hijacking glucose transporters
and are actively removed by MRPs.
Uptake of (Glycosylated) Phytosterols
In the lumen of the intestine the poorly water-soluble
phytosterols are incorporated into micelles that allow close
contact with the surface of enterocytes (Gylling et al., 2014).
Next, phytosterols are thought to be internalized by the mucosal
intestinal cells via the Niemann–Pick C1-Like1 (NPC1L1)-
transporter. Subsequently, plant sterols are re-secreted into
the lumen of the intestine via ABCG5/ABCG8 transporter
complex (as discussed in section “Glycosylated Lipids”). In the
liver, the ABCG5/ABCG8 complex mediates efflux of plant
sterols into bile (Gylling et al., 2014). Plant sterols manage
to pass the BBB and therefore potentially may influence brain
function (Jansen et al., 2006; Vanmierlo et al., 2012). This
notion raises considerations regarding excessive consumption
of olive oil containing high amounts of plant sterols. The
poor solubility of phytosterol in both water and oil limits
absorption. Esterification of phytosterols increases their solubility
in oil and margarine (Ostlund, 2004). Regarding glycosylated
phytosterols it is clear that these reach tissues, including
the brain (see section “Glycosylated Lipids”). Relatively little
is, however, known with respect to transporter proteins
involved in the uptake glycosylated sterols. They have been
reported to be absorbed intact and exert as such their effects




All domains of living organisms contain multiple glycoside
hydrolases (GHs, glycosidases). These enzymes play a variety
of functions, including the lysosomal metabolism of glycolipids
in animals, the catabolism of cell wall polysaccharides in
plants and biomass conversion in microorganisms (Leah
et al., 1995; Ketudat Cairns and Esen, 2010). More than
160 GH families have been listed in the Carbohydrate Active
EnZymes (CAZy) database using a classification system based
on amino acid sequence and secondary structure similarities
(Henrissat, 1991; Ben Bdira et al., 2018). This classification
system is regularly updated and new families are continuously
discovered. Additionally, the enzymes are classified based on
their reaction mechanism, according to the stereochemical
outcome of the hydrolytic reaction, into inverting or retaining
enzymes (Koshland, 1953; Sinnott, 1990). Moreover, glycosidases
are also classified as exo- or endo-enzymes, depending on
their ability to cleave at the end or in the middle of a
carbohydrate chain.
Plants contain numerous CAZy-encoding genes, more than
any other organism. For instance, Arabidopsis contains over
400 different genes encoding glycosidases (Husaini et al., 2018).
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This complexity stems from gene duplications and has likely
been promoted by the increasingly complex plant cell wall
structure, as described for Arabidopsis by Bowers et al. (2003).
Some proteins, based on homology designated as glycosidases
or glycosyltranferases might have further evolved to act on
different types of substrates or to fulfill other non-enzymatic
functions (Coutinho et al., 2003). An example is the soybean
hydroxyisourate hydrolase. Even though the enzyme has a
highly conserved retaining β-glucosidase active site, it catalyzes
the hydrolysis of 5-hydroxyisourate (Raychaudhuri and Tipton,
2003). Therefore, caution when talking about plant glycosidases
and GTs is necessary.
Particularly ubiquitous in plants are β-glucosidases. Most
plant β-glucosidases (E.C.3.2.1.21) are mainly classified in the
glycoside hydrolase family 1 (GH1) of the CAZy database.
However, some plant β-glucosidases are grouped in GH families
5 and 30. They all fall in GH Clan A, and contain similar
(β/α)8-barrel structures. They consistently share an active site
with two catalytic residues (Morant et al., 2008; Ketudat
Cairns and Esen, 2010). Their main activity, even though
it is not restricted, accounts to the hydrolysis of the (β-
glucosidic bond between carbohydrates or between a sugar and
an aglycone moiety.
Plant β-glucosidases play a number of important biological
roles. For instance, they are involved in cell wall degradation
during endosperm germination (Leah et al., 1995). The enzymes
together with other plant and microbial glycosidases and
glycanases degrade the plant cell wall, leading to formation of
intermediates for cell wall lignification (Dharmawardhana et al.,
1995; Escamilla-Treviño et al., 2006). Over different enzymes
have been reported taking a part in this process (Mohnen,
2008). Furthermore, β-glucosidases are involved in activation of
phytohormones (Kristoffersen et al., 2000; Lee et al., 2006). They
participate in plant defense mechanisms via activating several
chemical defense compounds, like phytohormones, flavonoids
and cyanogenic glucosides (Nisius, 1988; Poulton, 1990; Suzuki
et al., 2006; Morant et al., 2008). For instance, a cyanogenic
glucosidase (linamarase) from cassava and white clove is able
to cleave glucosides from glucosylated cyanosides releasing toxic
HCN as a defense mechanism (Oxtoby et al., 1991; Hughes
et al., 1992). In addition, a β-glucosidase from maize was found
to be active toward cytokinin-O-glucosides and kinetin-N3-
glucoside, releasing active cytokinin (Brzobohaty et al., 1993).
Furthermore, they are reported to release volatiles like flower
scents from their glycoside storage forms (Sarry and Günata,
2004). Due to the high number of different plant glucosides, it
is very likely that plant glucosidases play other roles that are yet
to be discovered.
Catalytic Mechanism of Glucosidases
Two carboxyl-exposing residues in the active site of both
inverting and retaining β-glucosidases enzymes take part in
the hydrolysis of the glycosidic bond (Koshland, 1953). In the
case of inverting enzymes, these two groups are separated at
a distance of 6–12 Å, whereas in retaining enzymes, this is
∼5 Å. The inverting reaction is a single step reaction; a direct
displacement of the aglycone, where one carboxylic group is
acting as the base and it activates a water molecule that hydrolyzes
the glycosidic bond through a nucleophilic attack at the anomeric
center (Guce et al., 2010) and at the same time, the second
carboxylic acid facilitates the departure of the leaving group via
acid catalysis. On the contrary, retaining glycosidases employ a
double displacement mechanism (Koshland, 1953). The reaction
initiates with the nucleophilic attack to the anomeric center,
resulting in a glycosyl-enzyme covalent intermediate. Then, the
deprotonated carboxylate acts as a base and deprotonates a
water molecule, that now plays the role of a nucleophile, to
hydrolyze the covalent intermediate giving the reaction product.
The transfer of a released sugar from a substrate to an acceptor
other than a water molecule is called transglycosylation, and
has been observed for several retaining glycosidases (Sinnott,
1990; Hehre, 2001). The acceptor molecules can be sugars,
as in the case of chitotriosidase (Aguilera et al., 2003),
but also retinol or sterol in the case of glucocerebrosidase,
the human β-glucosidase (Vanderjagt et al., 1994). Akiyama
et al. (2013) and Marques et al. (2016a) reported the use of
glucosylceramide as sugar donor in the formation of cholesterol
glucoside via β-glucosidase mediated transglucosylation. Several
examples of transglycosylation activity of plant and bacterial
glycosidases have also been reported (Crout and Vic, 1998;
Morant et al., 2008).
Glycosyltransferases
The CAZy database currently contains 110 GTs. In plants,
GTs have many functions, for example in the biosynthesis
of glycosylated metabolites, oligosaccharides, polysaccharides
(cellulose, hemicelluloses, and pectins among others), and
glycoproteins in the plant cell membrane (Hansen et al.,
2012). The polysaccharides and other glycans are mainly
synthesized by GTs (EC 2.4.x.y). Most GTs (Leloir GTS)
transfer a sugar residue from an activated nucleotide sugar
to a specific acceptor molecule, with high specificity for the
sugar donor and the acceptor substrates (Breton et al., 2005).
GTs are classified as retaining or inverting depending on
whether glycosylation results in net retention or inversion
of stereochemistry at the anomeric carbon of the donor
substrate. GTs are classified in the CAZy database into
families on the basis of amino acid sequence similarities
(Cantarel et al., 2009). Two major folds of structures of
nucleotide–sugar-dependent GTs solved to date are observed,
termed GT-A and GT-B (Hansen et al., 2010). Many GT-
Bs are independent of a metal ion for catalysis, whereas
most GT-A enzymes contains a conserved DxD motif that
coordinates the phosphate atoms of the nucleotide donors via
coordination of a divalent cation, usually Mn2+ or Mg2+
(Breton et al., 2005). Besides GTs using sugar mono- or
diphosphonucleotide donors, known as Leloir type GTs, two
additional group of glucosyltransferases occur: non-Leloir-type
GTs which employ sugar lipid phosphates, pyrophosphates
or polyprenol phosphates as donors, and non-activated acyl-
glucose dependent glucosyltransferases. This last group of
enzymes are transglucosidases related to GH1 family hydrolases.
One example of this is the rice β-glucosidase Os9BGlu31
that uses glucopyranosides as well 1-O-acyl glucose esters
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as sugar donors in synthetic reactions (Luang et al., 2013;
Komvongsa et al., 2015).
NEW TOOLS TO EXPLORE “PLANT”
GLYCOSIDASES; ACTIVITY BASED
PROBES (ABPs) FOR RETAINING
GLYCOSIDASES
Detailed knowledge on the reaction mechanism of retaining
glycosidases has allowed the generation of ABPs, a new class of
versatile research tools (for a recent review see Wu et al., 2019).
ABPs, Principles and Applications
Through Time
The idea to exploit covalent inhibitors of active enzymes as ABPs
was firstly put forward for esterases by Ostrowski and Barnard
(1961). The concept was further pioneered by Cravatt et al. (2008)
for several enzyme classes. Now, ABPs have been designed for
kinases, proteases, serine hydrolases, lipases and glycosidases
(Cravatt et al., 2008; Witte et al., 2010, 2011; Serim et al., 2012;
Baggelaar et al., 2013; Kallemeijn et al., 2014; Willems et al.,
2014b; Kuo et al., 2018).
In the case of retaining glycosidases, the use of irreversible
inhibitors optimally mimicking the oxocarbenium ion-like
transition state of the target enzyme has promoted the design
of diverse ABPs. Wicki et al. (2002) and Goddard-Borger
et al. (2010) first proposed the use of fluorinated inhibitors
for targeting human β-glucosidase. Chauvigné-Hines et al.
(2012) generated difluoromethylphenyl aglycone, N-halogenated
glycosylamine, and 2-deoxy-2-fluoroglucoside ABPs to identify
reactive glycosidases in the cellulosomal secretome of Clostridium
thermocellum. Their study identified a wide number of cellulases,
xylanases, hemicellulases, and CAZys. More specific, they
were able to identify both inverting and retaining enzymes
that were listed in different GH families. Some of them
play an important role in the degradation of cellulose: GH9
(inverting) cellulase enzymes, a number of GH5 (retaining)
endoglucanases, and GH10 and GH11 (retaining) xylanases
(Chauvigné-Hines et al., 2012).
The first retaining (β-glucosidase for which a high affinity
and highly selective ABP was designed has been human
glucocerebrosidase. A decade ago, Witte et al. (2010)
demonstrated that cyclophellitol based ABPs irreversibly
bind and enable identification of GBA (human lysosomal
β-glucosidase; glucocerebrosidase) in complex biological
samples, such as cell lysates, cell cultures, and laboratory animals.
This ABP has meanwhile found important applications in studies
on Gaucher disease, an inherited lysosomal storage disorder
caused by GBA deficiency. Its use for diagnostic purposes holds
great promise (Aerts et al., 2011). The glucosyl-configured
cyclophellitol ABP binds covalently to the catalytic nucleophile,
Glu-340, of the human GBA enzyme (Figure 3A). In addition
to the cyclophellitol sugar, the probes contain a reporter group,
that can be a fluorophore and/or biotin, attached via a linker to
the C-6 position of the functionalized cyclophellitol, enabling the
visualization and/or identification of active enzyme molecules
(Witte et al., 2010).
Next, a different class of ABPs was designed by Overkleeft
for retaining β-glucosidases based on the use of cyclophellitol-
aziridine scaffolds (Kallemeijn et al., 2012) (Figures 3A,B).
Subsequently, by variation of the configuration of cyclophellitol-
aziridine a series of new probes were developed for other
retaining glycosidases. Detection of active α-D-galactosidase
(Willems et al., 2014a), β-D-galactosidase (Marques et al., 2016b),
α-L-fucosidase (Jiang et al., 2015), α-D-glucosidases (Jiang et al.,
2016), β-D-glucuronidase (Wu et al., 2017), α-L-iduronidase
(Artola et al., 2018) and α-L-arabinofuranosidases (McGregor
et al., 2020) was achieved with these types of ABPs. Through
changing the reporter group into a biotin, the probes can
be used for streptavidin-mediated enrichment, followed by
proteomics identification of labeled proteins using LC-MS/MS
(Jiang et al., 2016). Meanwhile, many research applications for
glycosidase ABPs have been found. The amphiphilic nature
of glycosidase ABPs enables them to penetrate cells and
organisms, allowing in situ labeling of active enzyme molecules
in lysosomes. Intravenous infusion of mice with ABPs resulted
in specific labeling of GBA in various tissues (Kallemeijn et al.,
2012). More recently, the same ABPs were employed to very
sensitively visualize active GBA molecules in lysosomes of
cells by correlative light electron microscopy (CLEM) (Van
Meel et al., 2019). Visualization of GBA in the brain of mice
was also achieved after intracerebroventricular administration
of the ABP (Herrera Moro Chao et al., 2015). Application
of ABPs in studies with zebrafish models of GBA enzyme
deficiency have been recently described (Artola et al., 2019;
Lelieveld et al., 2019). In addition, β-D-glucuronidase ABPs
have recently been employed in fecal samples to study the
anticancer Irinotecan drug toxicity driven by gut microbial
enzymes (Jariwala et al., 2020).
ABPs in Plant Science
Plant scientists interested in hydrolases have to deal with a
huge number of genes encoding potential glycosidases. Moreover,
transcript expression levels do not always correlate with actual
active enzyme levels. Therefore, methods for conveniently
monitoring distinct active glycosidases are in great demand
to establish the functional proteome of different plant species.
ABPs provide a novel toolbox for this purpose which has been
successfully applied in plant science during the last decade (van
der Hoorn and Morimoto, 2016). Enzymes of several families
have been identified and functionally characterized using ABPs,
such as serine hydrolases (Kaschani et al., 2009), papain-like
cysteine proteases (Richau et al., 2012) and cysteine proteases (Lu
et al., 2015). In addition, retaining glycosidases of different plant
species have been characterized and identified (Chandrasekar
et al., 2014; Husaini et al., 2018; Kytidou et al., 2018). The use
of ABPs as functional tool for studying retaining glycosidases
in plants was first reported by the group of Chandrasekar et al.
(2014). The chemical structures of ABPs used in this research are
depicted in Figure 3B. An overview is provided in Figure 3C
of key publications describing specific applications of ABPs in
research using several plant species.
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FIGURE 3 | Activity based probes mechanism and use in plant science. (A) Mechanism of aziridine and epoxide activity-based probes. (B) Structures of ABPs used
in plant science. (C) Summary of published ABPs used in plant research. Presented are key publications describing specific applications in plant species.
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The (β-D-glucose configured cyclophellitol-aziridines JJB70
conjugated with a BODIPY green fluorophore and JJB111
conjugated with a biotin was combined with proteomic analysis
of targeted protein to study glycosidases in Arabidopsis thaliana
total leaf samples and in N. benthamiana apoplast samples
(Chandrasekar et al., 2014). KY371 probe, which does not
contain any reporter group, was applied as competitor to ensure
that protein labeling was specific. The investigation revealed
that the aziridine type β-glucosidase ABPs present a broad
activity, enabling identification of not only β-glucosidases but
also myrosinases, xylosidases, and galactosidases. Importantly,
very high (micromolar) concentrations of ABP were used in the
study which favors detection of different classes of glycosidases.
The identified proteins are members of seven different retaining
glycosidase families (Chandrasekar et al., 2014). Of note, no
cellulases were identified. The main identified proteins were the
β-thioglucoside glucohydrolase TGG2 (68-kDa signal) and TGG1
(75-kDa signal). Both enzymes are myrosinases and catalyze
the conversion of glucosinolates during attack of invaders.
Interestingly, yet uncharacterized glycosidases, one of which was
previously classified as pseudogene (TGG3), were identified in
the study. An investigation with the ABP of secreted proteins
by N. benthamiana cells led to the identification a wide range of
putative xylosidases, galactosidases, glucanases, and heparanase.
In addition, in situ labeling of active glycosidases present in
Arabidopsis cell cultures revealed that ABPs (KY371 and JJB70)
can penetrate living plant cells and therefore can be fortuitously
also used to generate knock out models. Furthermore, van
der Hoorn and Morimoto (2016) explored the presence of
glycosidases in different (tissues of) plant species like Brassica
napus, Brassica oleracea, Brassica rapa, Brassica pekinensis,
Triticum monococcum, Zea mays, Avena sativa, and Nicotiana
benthamiana via in-gel imaging (Chandrasekar et al., 2014) (see
Figure 3C).
Next, Daneri-Castro et al. (2016) used ABPs to identify and
characterize enzymes that are secreted by the aleurone layer
during barley germination and are induced or not by gibberellic
acid (GA). They employed different ABP classes and thus were
able to identify putative aleurains, cathepsin-B-like proteases
and serine hydrolases. JJB70 ABP, targeting active retaining
glycosidases, was used to demonstrate the presence of a putative
xylanase in barley aleurone by competing the labeling with xylose
(Daneri-Castro et al., 2016). More recent, ABPs targeting (α-
glucosidases have been used in investigations on Arabidopsis
and saffron crocus (Crocus sativus) (Husaini et al., 2018).
Interestingly, using the α-glucosidase ABP (JJB383) evidence was
obtained that during stigma development in saffron glycosidases
are involved in the conversion of picrocrocin into safranal.
Furthermore, during Fox infection the enzyme AGLU1 was
detected to be present in the apoplast. In the same study, parallel
analysis of both α- and β-glucosidases was performed, enabling
simultaneous identification of different enzyme classes (Husaini
et al., 2018). In conclusion, ABPs find very broad applications in
investigations on plant metabolism and physiology.
Activity-based probes have also already been successfully
used to monitor recombinant active enzyme during transient
expressions in N. benthamiana plants. Human α-galactosidases
have been produced in N. benthamiana leaves and in HEK293 cell
cultures (Kytidou et al., 2017). Recombinant protein was detected
and quantified using the α-galactosyl configured cyclophellitol-
aziridine TB474 containing a Cy5 fluorophore (Kytidou et al.,
2017). This detection method is superior to western-blot since
it allows selective detection of active enzyme molecules. Based
on previous investigations, it might be concluded that ABPs
can be applied as an easy quantitative method to follow the
production of biopharmaceuticals in recombinant systems. In
addition, the use of the biotinylated ABP, ME741, enabled the
identification of a novel N. benthamiana galactosidase, named
A1.1. The enzyme was then overexpressed in N. benthamiana
leaves, purified and further biochemically characterized. One of
the most important findings was that A1.1 proves to be able
to hydrolyze human glycosphingolipids in vitro and in situ and
might find applications in the treatment of Fabry disease, caused
by deficiency of the human α-galactosidase (Kytidou et al., 2018).
Therapeutic application of a plant enzyme, discovered with an
ABP, for treatment of a human metabolic disease can be thus be
envisioned (Figures 3B,C).
The specificity of ABP labeling of glycosidases can be
fine-tuned by the assay conditions (e.g., variation of pH),
concentration of probe and use of competitive inhibitors. The
ABPs can in principle be used to visualize glycosidases during
physiological processes of interest such as plant development,
seed germination, cell wall formation and different responses to
biotic and abiotic stresses.
PRODUCTION OF THERAPEUTIC
(HUMAN) GLYCOSIDASES IN PLANTS
History
Production of biopharmaceutical proteins in plants is undertaken
since the early 2000s. It gained great attention due to the
advantages in economy, safety and scalability with several
examples of in planta recombinant protein productions over the
last decades (Westerhof et al., 2014; Wilbers et al., 2017). The
first plant-produced protein was the human growth hormone, in
1986, in tobacco cell cultures (Fischer et al., 2004). After that, a
vast number of different proteins have been produced in planta,
demonstrating the viability of such methods for industrial
and pharmaceutical uses (Hidalgo et al., 2018; Kopertekh and
Schiemann, 2019). A recent example is the large scale production
of the drug ZMapp in 2014 in tobacco leaves for use against Ebola
virus (Yao et al., 2015). This review focuses on the production
of therapeutic human glycosidases in plants for the treatment of
lysosomal diseases.
Lysosomal Enzymes and Their
Production in Plants
Lysosomal diseases are inherited metabolic diseases caused
by dysfunction of lysosomal hydrolases. A possible therapy
for these diseases involves replacement of deficient enzymes
by their normal equivalents. Supplementation of patient cells
is envisioned following intravenous administration (infusion)
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of recombinant enzyme. This concept was developed and
pioneered by Brady and is known as enzyme replacement
therapy (ERT) (Brady, 2003; Desnick and Schuchman, 2012;
Aerts and Cox, 2018). The uptake of the recombinant
enzyme preparations is usually mediated by mannose receptors
(MR) which are present in the surface of the targeted
cells and also via mannose-6-phosphate receptors (M6PR)
and the asialoglycoprotein receptor (Ashwell-Morell receptor;
AMR) (Figure 4) (Coutinho et al., 2012; Shen et al., 2016;
Tian et al., 2019). Examples of such disorders and their
corresponding impaired glycosidase are Gaucher disease and
β-glucocerebrosidase (GBA), Fabry disease and α-galactosidase
(GLA), Pompe disease and α-glucosidase (GAA) and Krabbe
disease and β-galactocerebrosidase (GALC).
The production of the lysosomal human GBA enzyme in
carrot cells by Shaaltiel et al. (2007) can be considered as a
hallmark in the production of pharmaceutical glycosidases
in plants for the treatment of lysosomal diseases. The plant
produced enzyme, ELELYSO (taliglucerase alfa) (Protalix
BioTherapeutics), was approved by the FDA in May 2012.
The enzyme is targeted to the vacuoles of carrot cells via the
insertion of a chitinase (“GLLVDTM”) vacuole signal peptide.
The recombinant enzyme has high mannose terminal N-glycans
that mediate uptake by macrophages (Shaaltiel et al., 2007). It
was firstly demonstrated that the plant specific N-glycans on
the plant produced recombinant GBA are not immunogenic, a
crucial finding. Production of human GBA enzyme in transgenic,
complex-glycan-deficient, Arabidopsis seeds, has also been
achieved (He et al., 2011). The produced enzyme in the latter case
does not contain any targeting signal to the vacuole. Active GBA
has recently also been produced in root cultures of Nicotiana
tobacco (Naphatsamon et al., 2018). Finally, GBA enzyme with
high mannose N-glycans (gnt1-GBA) was produced in mutant
rice (Jung et al., 2019).
Another human lysosomal hydrolase produced in plants is
α-galactosidase A. The production of this enzyme for therapy
of Fabry disease was firstly accomplished in tobacco cell
cultures in 2015 (Kizhner et al., 2015; Ruderfer et al., 2018;
Schiffmann et al., 2019). The protein, pegunigalsidase alfa,
PRX-102 (Protalix BioTherapeutics), is currently in clinical
trials and it is produced in large scale at ProCellEx plant
cell-based protein expression platform (Ruderfer et al., 2018).
Interestingly, the recombinant protein is chemically modified
with a bifunctional PEG polymer to form stable dimers. Such
modification improves the enzyme’s stability in plasma and
its pharmacokinetic properties (Ruderfer et al., 2018). PRX-
102 is found superior in stability than the current available
recombinant enzymes for treatment of Fabry disease (agalsidase
beta, Fabrazyme and agalsidase alpha, Replagal) which are both
produced in mammalian cell culture systems. Of note, no M6P
residues are present in the N-linked glycans of pegunigalsidase
alfa. A mannose enriched human α-galactosidase A was produced
in 2016 in moss cell cultures (Shen et al., 2016). The enzyme
was found to be effectively targeted through the MR pathway to
defective organs such as heart and kidney. α-Galactosidase was
also produced transiently in N. benthamiana leaves for research
purposes (Kytidou et al., 2017). In parallel, in the same platform
human α-N-acetylgalactosaminidase and a mutated form with
increase α-galactosidase activity was generated (Tajima et al.,
2009; Kytidou et al., 2017). Finally, a modified fragment of human
α-glucosidase (GAA) has been produced in plant chloroplasts
to induce tolerance against human GAA in Pompe disease
patients receiving ERT (Su et al., 2015). Future investigations will
demonstrate clinical benefit of this approach.
N-Glycoengineering
The feasibility to manipulate and humanize the N-glycosylation
pathway of plants offers a great advantage in the production
of biopharmaceuticals (Castilho and Steinkellner, 2012; Bosch
et al., 2013). N-Glycosylation of glycoproteins in plants and
mammals is identical up to the formation of the vital intermediate
“GlcNAc2Man3GlcNAc2” N-glycan (GnGn structure) in medial-
Golgi apparatus (Figure 4A) (Gomord et al., 2010). Further
modification of the GnGn structure takes place in mammals
in trans-Golgi apparatus, resulting in complex and highly
heterogenic N-glycan structures whereas in plants further
modifications are not as frequent and mainly include the
addition of β(1,2)-xylose and α(1,3)-fucose residues at core
GnGn structure (Gomord and Faye, 2004). Additionally, high
mannose, paucimannosidic structures and also Lewis-X- epitopes
are frequently observed in N-glycans of plant glycoproteins.
Even though core fucosylation may occur in mammals this
involves addition of α(1,6)-linked fucose residues (Bosch et al.,
2013). Several examples of N-glycoengineering plants to reach a
human like N-glycan profile have been reported and reviewed
(Castilho and Steinkellner, 2012; Bosch et al., 2013). Using
reverse genetics (CRISPR/cas9 knock out, RNAi methods), plants
were generated lacking endogenous activities such as the ones
of β (1,2)-xylosyltransferase and core α (1,3)-fucosyltransferase
responsible for attaching plant-specific residues to core glycan
structures (Jansing et al., 2019). This was first accomplished in
Arabidopsis thaliana plants followed by Nicotiana benthamiana,
Lemna minor, and the moss Physcomitrella patens and rice cells
(Strasser et al., 2004; Schähs et al., 2007; Loos et al., 2011; Castilho
and Steinkellner, 2012; Bosch et al., 2013).
During ERT of patients suffering from glycosidase
deficiencies, intravenously infused recombinant enzymes
are endocytosed via lectin-mediated pathways. In the case of
Gaucher disease, ERT is highly successful since the recombinant
enzyme is targeted efficiently to macrophages (the primary
storage cells) via MR-mediated uptake (see above and Figure 4B).
In other LSDs, however, several cell types are affected and need to
be supplemented with therapeutic enzyme. For this reason, use
of the ubiquitous M6PR uptake is envisioned and recombinant
enzyme with a high M6P content in their N-glycans are produced
(Schiffmann et al., 2001; Eng et al., 2001; Kroos et al., 2012; Ferraz
et al., 2014). Thus, the N-glycan profile of the therapeutic enzyme
plays a key role in its availability, targeting and bioactivity.
The α-galactosidase produced in moss by Shen et al. (2016) is
claimed to be endocytosed by many cell types via mannose-lectin
mediated uptake. The enzyme has high mannose N-glycans that
lack the plant specific α (1,3)-fucose and β (1,2)-xylose residues
(Shen et al., 2016).
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FIGURE 4 | Plant and human N-glycosylation pathways: importance in production of pharmaceuticals. (A) N-linked glycosylation pathway of proteins produced in
plants and humans. (B) The lectin mediated uptake of recombinant enzymes from cells for the treatment of LSDs.
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FIGURE 5 | Principle of activity-based protein profiling for target identification and competitive activity-based protein profiling for the screening of glycosidase
inhibitors. The competition of ABP labeling of a glycosidase by agents interacting with its pocket (inhibitors, substrates) can be conveniently and sensitively
assessed. there is no need for a pure enzyme, when visualizing labeled glycosidase using SDS-PAGE and fluorescence scanning.
ABPs: LINKING RETAINING
GLYCOSIDASES WITH SMALL
COMPOUND INTERACTORS OF THEIR
CATALYTIC POCKETS
The previous sections of this review largely focused on
glycosylated metabolites on the one hand and retaining
glycosidases on the other hand. In addition, the design
and application of ABP reacting in a mechanism-based
manner with the catalytic nucleophile of specific glycosidases
was introduced. In this section, the use of ABPs to
‘bridge’ glycosidases with interacting small compounds
is discussed.
The great value of ABPs to identify, purify and characterize
glycosidases from various plants has been addressed in the
previous sections. Some of these enzymes might find future
applications as drugs or in industrial processes. Another
application for ABPs warrants discussion. By virtue, ABPs
can be also used to identify small compounds that interact
with the catalytic pocket of the reactive glycosidase. Such
interactors, (substrates, inhibitors), will compete with the ABP
for occupancy of the pocket and the subsequent labeling of
the enzyme (Figure 5). This concept can for example be
exploited to screen different plant extracts or selected compounds
(glycosylated plant sterols and flavonoids) for interaction with
(plant or human) glycosidases as revealed by the competition
of labeling of the glycosidase with the corresponding ABP.
Proof of principle for such screens has already been obtained.
In this manner, inhibitors have been identified for the human
non-lysosomal glucosylceramidase GBA2, an enzyme that is
difficult to purify to homogeneity in active form. Lahav et al.
(2017) used a fluorescent polarization activity-based protein
profiling (ABPP) assay where they successfully screened a
library of 350+ iminosugars for potential GBA2 inhibitors using
a lysate of cells over-expressing GBA2 and the appropriate
glucosidase ABP (Lahav et al., 2017). In the same manner,
complex biological samples can be screened on the presence
of potential substrates for a glycosidase competing with ABP
labeling. One further application along the same line is the use of
cell-permeable ABP labeling of a glycosidase to identify the in situ
inhibition of a target glycosidase by an administered inhibitor.
An example of such application is provided by a recent study
identifying in intact cells and zebrafish the β-glucosidase target
engagement of conduritol B-epoxide and cyclophellitol analogs
(Kuo et al., 2019).
In conclusion, ABPs will not only be of value to study their
target glycosidases but also interactors of their catalytic pockets.
SUMMARY AND PERSPECTIVES
Natural plant-derived glycosides are used for various therapeutic
purposes. Increased knowledge of beneficial/toxic effects is
warranted. This is particularly relevant for plant sterols for
which beneficial and potentially harmful effects have been
reported. Better insight is needed regarding the biological effects,
bioavailability and metabolism of glycosylated sterols prior to
any clinical use in prevention/treatment of diseases. This may
also hold for other plant metabolites. The therapeutic value of
infusion of glycosidases in treatment of inherited deficiencies
in man has been demonstrated for a number of diseases. In
recent years, production of such glycosidase increasingly occurs
in plant platforms that offer several advantages. Importantly, the
N-glycan composition of plant-produced recombinant enzymes
can be very well controlled using genetically modified plants.
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The ubiquitous plant glycosidases themselves might conceivably
find therapeutic applications in humans and might have
potential to treat inherited glycosidase deficiencies in man
(Kytidou et al., 2018). Overall, ABPs may help to identify plant
glycosidases of interest.
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